Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Is There an Answer?

Is There an Answer? Is There An Answer? is intended to serve as a forum in which readers to IUBMB Life may pose questions of the type that intrigue biochemists but for which there may be no obvious answer or one may be available but not widely known or easily accessible. Readers are invited to e-mail f.vella@sasktel.net if they have questions to contribute or if they can provide answers to questions that are provided here from time to time. In the latter case, instructions will be sent to interested readers. Answers should be, whenever possible, evidencebased and provide relevant references. —Frank Vella Q&A Question: Are patients taking statins, which are HMG-CoA reductase inhibitors, to reduce their cholesterol, in danger of being deficient in coenzyme Q? Answer: E J Wood, School of Biochemistry & Microbiology, University of Leeds, Leeds LS2 9JT, UK. E-mail: e.j.wood@Leeds.ac.uk All the isoprenoid derivatives are synthesized by a common pathway through HMG-CoA reductase (Fig. 1). Cholesterol and other sterols are made by this route, but of course cholesterol is also obtained from the diet. Statins are drugs that are widely used for treating hypercholesterolemia and numerous epidemiological studies have demonstrated their efficacy in reducing total plasma cholesterol and the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png IUBMB Life Wiley

Is There an Answer?

IUBMB Life , Volume 56 (7) – Jul 1, 2004

Loading next page...
 
/lp/wiley/is-there-an-answer-bDCoxtI747

References (19)

Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2004 International Union of Biochemistry and Molecular Biology
ISSN
1521-6543
eISSN
1521-6551
DOI
10.1080/15216540400008960
pmid
15545221
Publisher site
See Article on Publisher Site

Abstract

Is There An Answer? is intended to serve as a forum in which readers to IUBMB Life may pose questions of the type that intrigue biochemists but for which there may be no obvious answer or one may be available but not widely known or easily accessible. Readers are invited to e-mail f.vella@sasktel.net if they have questions to contribute or if they can provide answers to questions that are provided here from time to time. In the latter case, instructions will be sent to interested readers. Answers should be, whenever possible, evidencebased and provide relevant references. —Frank Vella Q&A Question: Are patients taking statins, which are HMG-CoA reductase inhibitors, to reduce their cholesterol, in danger of being deficient in coenzyme Q? Answer: E J Wood, School of Biochemistry & Microbiology, University of Leeds, Leeds LS2 9JT, UK. E-mail: e.j.wood@Leeds.ac.uk All the isoprenoid derivatives are synthesized by a common pathway through HMG-CoA reductase (Fig. 1). Cholesterol and other sterols are made by this route, but of course cholesterol is also obtained from the diet. Statins are drugs that are widely used for treating hypercholesterolemia and numerous epidemiological studies have demonstrated their efficacy in reducing total plasma cholesterol and the

Journal

IUBMB LifeWiley

Published: Jul 1, 2004

There are no references for this article.